I1171S previously was seen in an in vitro accelerated mutagenesis screen in ALK+ NSCLC using increasing concentrations of crizotinib [36] and somatic mutations in this residue also have been reported in neuroblastoma [10, 37]. Here, ALK is linked to non-small cell lung carcinoma.